Cigna Group's (CI) Q3 beat was driven by solid performance in Cigna Healthcare and continued momentum in Specialty and Care Services, RBC Capital Markets said in a note Wednesday.
Following the results, management expressed confidence in achieving at least 10% adjusted earnings per share growth from an about $30 base, adjusted for its exit from the Affordable Care Act, or ACA, exchange market, the analysts said.
The analysts said they are raising their 2026 adjusted EPS estimate to $30.66 from $30.49. However, they lowered their 2027 adjusted EPS estimate to $33.04 from $33.53.
The analysts added that this reduction mainly reflects stranded overhead costs from Cigna's ACA market exit and softer Evernorth margins due to smaller rebate pools and lower employer coverage of GLP-1 weight-loss drugs.
RBC raised its price target on Cigna to $346 from $337 while keeping its outperform rating.
Price: 271.94, Change: -13.44, Percent Change: -4.71